NCT Number: NCT02618395
Bioavailability Study of SPARC001 in Healthy Adult Volunteers
Bioavailability study
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 1
About this study
Bioavailability, safety and tolerability
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Adult, male and female volunteers, 18 to 55 years of age
- Body mass index (BMI) ≥18 to ≤30 kg/m2 at screening
- Female subjects must have a negative serum pregnancy test
- Medically healthy on the basis of medical history and physical examination
Exclusion criteria
- Females who are pregnant, lactating, or likely to become pregnant during the study
- Life-time history and/or recent evidence of alcohol
- History of hypersensitivity to hydrocodone, acetaminophen or any component of the test and reference formulations
- Subjects with any condition in which an opioid is contraindicated
Treatment and study plan
SPARC001B
DrugReference001 - Hydrocodone
DrugHydrocodone-acetaminophen
Primary outcomes
-
Maximum plasma hydrocodone and acetaminophen concentration (Cmax)
Time frame: 17 days
Secondary outcomes
-
AUC extrapolated to infinity (AUC0 ∞)
Time frame: 17 days
-
Time to Cmax (tmax)
Time frame: 17 days
-
Elimination half-life (t½)
Time frame: 17 days
-
Treatment emergent adverse event
Time frame: 17 days
Sponsors and collaborators
Lead sponsor
Sun Pharma Advanced Research Company Limited
Industry
Registry information
Important dates
- Study start
- 2015
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Dec 1, 2015
- Registry last updated
- May 3, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Tumor-Derived FGF19
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsAI Chatbot for HPV Vaccine Literacy Among Caregivers in Japan
NCT06702423
Healthy
London, United Kingdom
View Trial DetailsValidation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease
NCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNormative Value for Navicular Drop Test in Older Adults
NCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details